Takayuki Ozawa, Takafumi Yokota, Yasuhiro Shingai, Tomoaki Ueda, Yukiko Doi, Hirohiko Shibayama, Yuzuru Kanakura (Department of Hematology and Oncology, Osaka University, Suita, Japan)

Nobuhiko Yamauchi^1,2, Junichiro Yuda^1,2, Yosuke Togashi², Joji Nagasaki², Yosuke Minami¹, Hiroyoshi Nishikawa² (1.Department of Hematology, National Cancer Center East Hospital, 2.Division of Cancer Immunology, National Cancer Center)

Hideyuki Nakazawa¹, Nodoka Sekiguchi², Junji Suzumiya³, Ritsuro Suzuki³, Koichi Ohshima⁴, Olli Dufva^6,7, Wonseog Kim^9,10, Younghyeh Ko¹⁰, Satu Mustjoki^6,8, Fumihiro Ishida^1,5 (1.Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan, 2.Shinshu Cancer Center, Shinshu University School of Medicine, Matsumoto Japan, 3.Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan, 4.Department of Pathology, Kurume University School of Medicine, Kurume, Japan, 5.Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan, 6.Hematology Research Unit Helsinki, Helsinki University, Helsinki, Finland, 7.Department of Hematology, Helsinki University Hospital, Helsinki, Finland, 8.Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland, 9.Department of Pathology, Samsung Medical Center, Seoul, South Korea, 10.Sungkyunkwan University School of Medicine, Seoul, South Korea)

Toru Kawakami¹, Nodoka Sekiguchi^1,2, Jun Kobayashi^3,4, Taku Yamane⁵, Sayaka Nishina¹, Hitoshi Sakai¹, Yukio Hirabayashi⁶, Hideyuki Nakazawa¹, Fumihiro Ishida^1,3,5 (1.Hematol., Shinshu Univ., Matsumoto, Japan, 2.Comprehensive Cancer Ther., Shinshu Univ., Matsumoto, Japan, 3.Health and Medical Sci., Shinshu Univ., Matsumoto, Japan, 4.Laboratory Med., Nagano Children's Hospital, Azumino, Japan, 5.Biomedical Laboratory Med., Shinshu Univ., Matsumoto, Japan, 6.Division of Hematology, Matsumoto Medical Center, Matsumoto, Japan)

Masaharu Kawashima¹, Joaquim Carreras², Hiroshi Higuchi¹, Ryutaro Kotaki¹, Takahiro Hoshina¹, Susumu Goyama³, Toshio Kitamura³, Naoya Nakamura², Ai Kotani¹ (1.Hematol. and Oncol., Tokai Univ., Isehara Japan, 2.Pathol., Tokai Univ., Isehara Japan, 3.Div. Cell Therapy, Inst. Med. Sci., University of Tokyo, Japan)

Hirotaka Miyashita¹, Kazuki Taoka¹, Ayako Kume², Kazuhiro Toyama¹, Aya Ushiku², Yosuke Masamoto¹, Tetsuo Ushiku², Mineo Kurokawa¹ (1.Hematology Oncology, The University of Tokyo, Tokyo, Japan, 2.Department of Pathology, The University of Tokyo Hospital, Tokyo, Japan)